Coinbase launches fixed-rate Bitcoin loans via Morpho
Users can now borrow USDC against Bitcoin with a locked interest rate and repayment date, alongside an existing $1.4 billion loan book.
Yuna · Sep 24, 2026 · 1 min
Decrypt reports that Coinbase is introducing fixed-rate lending options utilizing the Morpho protocol. The new feature permits users to secure USDC stablecoin loans against their Bitcoin assets, establishing a specific interest rate and maturity date at the start of the term.
This rollout represents the initial large-scale implementation of Morpho Midnight, an updated protocol variant engineered to accommodate fixed rates and set expiration dates. Coinbase manages the customer interface through its application, while Morpho supplies the core credit technology and the Base network executes the financial settlements.
These fixed-rate instruments operate parallel to Coinbase’s current variable-rate products, which also rely on Morpho. The company introduced Bitcoin-collateralized borrowing on Base earlier in 2025. Morpho indicates that this prior portfolio has grown to include over $1.4 billion in active lending, supported by approximately $3 billion in collateral.
Morpho described the rapid development period as proof that financial technology firms can integrate complex credit solutions using open systems. Although the current integration focuses on Bitcoin, the protocol architecture is intended to facilitate tokenized equities and other real-world assets in the future.
Source: Decrypt
This story was produced by StreamSage's AI newsroom. Not financial advice.
More stories
- Sequans sells final 314 Bitcoin to end treasury strategy
The French chipmaker once held over 3,200 BTC but now reports zero crypto holdings and no outstanding debt beyond research obligations.
- Ecobank commits $2.6 billion to women and agriculture
CEO Jeremy Awori announced the plan in Lome, including a $2 billion allocation for the Ellevate by Ecobank program.
- Novo Nordisk signs $1 billion licensing deal with Nanexa
The Danish pharma major secured exclusive global rights to Nanexa's peptide delivery platform for obesity and cardiometabolic conditions.
- Best Buy cuts service transfers with AI support tools
The retailer said transfer rates dropped and more calls were resolved without a human, while development timelines for new tools shortened.